Literature DB >> 3884499

Three-dimensional structure of human renin.

K Akahane, H Umeyama, S Nakagawa, I Moriguchi, S Hirose, K Iizuka, K Murakami.   

Abstract

A three-dimensional model of human renin has been constructed based on the assumption that the overall folding of the aspartyl proteases is very similar. As a reference, we used penicillopepsin, the structure of which has been reported at a resolution of 1.8 A, and its main chain was traced to build a model of renin. The resulting structure seems to be stable from the hydrophobic and hydrophilic viewpoints. Comparison of the tertiary structure of human renin with that of penicillopepsin and mouse renin suggests the existence of a high structural homology as well as differences in the molecular geometry of the active sites that may influence the substrate specificity. The asparagine side chains in the glycosidation signal of Asn-X-Thr are exposed on the surface. Moreover, the site in human renin that corresponds to the proteolytic cleavage site in mouse renin also appears to be exposed on the surface so as to be easily scissored during the maturation process. The insertions and deletions of amino acid residues were found to arise on the surface, and in some places they occurred in complementary manners. Models of molecular complexes between human renin and renin inhibitor were constructed to understand the interacting modes that indicate how new renin inhibitors develop. Inhibitor-binding sites were directly assigned based on the models of the inhibitor-enzyme complex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884499     DOI: 10.1161/01.hyp.7.1.3

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

Review 1.  Renin inhibitors.

Authors:  W J Greenlee
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

Review 2.  Renin inhibitors as possible antihypertensive agents.

Authors:  K G Hofbauer; J M Wood
Journal:  Klin Wochenschr       Date:  1988-09-15

3.  Plasma and serum prorenin concentrations in diabetes, hypertension, and renal disease.

Authors:  Sayuki Kawamura; Kazumi Fujimoto; Akinori Hayashi; Yuji Kamata; Ibuki Moriguchi; Naoyuki Kobayashi; Masayoshi Shichiri
Journal:  Hypertens Res       Date:  2022-06-10       Impact factor: 5.528

4.  Characterization of human prorenin expressed in mammalian cells from cloned cDNA.

Authors:  L C Fritz; A E Arfsten; V J Dzau; S A Atlas; J D Baxter; J C Fiddes; J Shine; C L Cofer; P Kushner; P A Ponte
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  High-resolution X-ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme.

Authors:  A Sali; B Veerapandian; J B Cooper; S I Foundling; D J Hoover; T L Blundell
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

6.  Circulating prorenin: its molecular forms and plasma concentrations.

Authors:  Kazumi Fujimoto; Sayuki Kawamura; Satoru Bando; Yuji Kamata; Yoshio Kodera; Masayoshi Shichiri
Journal:  Hypertens Res       Date:  2021-02-10       Impact factor: 3.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.